ACTION, in conjunction with Berlin Heart, Inc., launched the first prospective FDA regulated device trial using a pediatric ventricular assist device (VAD) registry in November 2022. Enrollment in the trial has been completed as of August 11, 2023, just 10 months after launch.
“Learning networks in pediatric heart failure and transplantation” was published June 17, 2021 in Pediatric Transplantation. This ACTION publication defines “learning networks” and how they’re different from traditional clinical research …
After a heartbreaking experience, Liam and his family inspired providers across the country to rethink how they communicate and learn from one another. Now, with the ACTION collaborative, every patient has access to a healthcare community working together to provide the best care throughout their heart health journey.